Participate in a Diabetes Research Study
With more than 20 Canadians being diagnosed with a form of diabetes every hour, it is likely that diabetes affects you or a loved one.
Clinical research is a branch of medical science which involves human participants to better understand, prevent, diagnose and treat illnesses. The Diabetes Clinical Trials Unit (DCTU) at St. Joseph’s Health Care London is always conducting several clinical trials to advance our understanding of diabetes and develop new treatment strategies.
We follow strict ethical regulations to ensure the safety and comfort of all our participants; and our research team is always available to address questions and concerns, whether you are already enrolled in a study or are interested in getting started.
Explore recruiting studies below:
Study: EFFICIENT
A research study to see how well weekly Insulin Icodec maintains blood sugar levels compared to daily Basal Insulins in adults with Type 2 Diabetes
Sponsor: Novo Nordisk
This study compares a new, once-per-week insulin called insulin icodec, with other traditional insulins, taken once-per-day, in people with type 2 diabetes. The purpose of this study is to see how well the weekly insulin maintains blood sugar levels when compared to daily insulins. All of the insulins used in the study have already been approved for use in Canada. Enrolled participants will be randomly chosen to be treated with either the weekly insulin or the daily basal insulin. The study will last for about 13 months after enrolment.
We are looking for patients who:
- Are 18+ years old
- Have been diagnosed with type 2 diabetes at least 6 months ago
- Have never taken insulin before
- HbA1c ≥ 7% in the last 3 months
If this sounds like you, or if you have any questions, please contact:
@email or (519) 646-6100 x 61222 for more information.
Read more about the study here.